Are you experiencing night driving problems? Are colors fading? If you are over the age of 50 years old you may be experiencing the onset of cataracts. Our doctors are skilled board certified cataract surgeons located in Portland, Maine. Our doctors take great pride in educating patients about their best options for success after cataract surgery. Please feel free to review our website to learn about new technology lens implants.
Learn about the latest news, promotions and events happening at Maine Eye Center!.
If you are seeking LASIK in Portland, Maine we are happy to help you learn about LASIK and your candidacy potential for this eye surgery. Please feel free to take our short LASIK self-evaluation test to get on the path to better vision. After taking this test you will be contacted by Maine Eye Center if you meet the pre-requisite requirements. All LASIK candidates will be required to undergo a pre-operative eye exam before candidacy is approved.
Please feel free to watch our educational video series. Click here to see videos of our patients and doctors for better insight into the eye surgery of your choice.
Thank you for visiting the website of Maine Eye Center. We hope that you found our eye care website information useful. If you have additional questions or wish to contact our office please fill out our contact form.
According to the Macular Degeneration Foundation, macular degeneration is the most frequent cause of legal vision loss for patients aged 55 and above in the United States and is estimated to affect over 10 million Americans. This is a serious degenerative eye disease that may require immediate attention from a medical ophthalmologist.
Before you can start to learn about macular degeneration and why this disease can lead to vision loss it is important to understand the retina and macula parts of the eye. Here are some important aspects to understanding the retina:
If the retina or macula have problems transmitting images through the optic nerve to the brain blindness can result.
Macular Degeneration, also called age related macular degeneration, affects primarily the aging population and gradually destroys central vision. As noted above the central vision is critical for seeing fine details and necessary for performing daily tasks such as reading and driving. This degenerative eye disease causes no pain and develops over a long period of time. Because this eye disease develops very slowly patients typically notice no change in their vision.
The Maine Eye Center retina eye doctors will determine regular follow-up appointments to monitor a macular degeneration condition by using an Amsler grid at least twice a week. This will help so that any changes in vision will be recognized as early as possible. The Maine Eye Center retina eye doctors will provide any instructions necessary to use the Amsler grid.
There are two forms of macular degeneration- dry and wet. The dry form is usually less severe and reading vision is often maintained.
This type of macular degeneration does not cause total blindness but typically worsens over time with the blurring vision and blind spots located in the central vision. Dry macular degeneration involves the presence of yellow deposits known as drussen in the macula. As these yellow spots grow in size and increase they will lead to a dimming effect or distortion of vision. In the advanced stage of dry macular degeneration central vision is lost but total blindness may not occur.
Wet macular degeneration affects much less of the total macular degeneration population. With wet macular degeneration blood vessels grow abnormally underneath the macula. These blood vessels leak blood and fluid into the retina, causing vision distortion. It is believed that the diseased retina stimulates the production of these new blood vessels in response to a decreased supply of nutrients and slow transport of wastes. Unfortunately, new blood vessels do not improve the health of the retina. Instead, they often leak blood or fluid into the retina.
Maine Eye Center provides various treatment options for macular degeneration including:
Lucentis is a prescription medication for the treatment of patients with wet macular degeneration. As mentioned earlier in on this page wet macular degeneration involves the leaking of blood vessels onto the retina. After receiving FDA approval in June of 2006 Lucentis has become a guiding light source for patients once facing blindness.
In order to get a Lucentis injection your eye will be prepped and cleaned in order to prevent any type of infection. Our retina specialists will then numb your eye to limit any discomfort. Patients do report slight pressure on the eye. Once the injection has passed the pressure will subside.
This drug was originally used for cancer patients but is now used to treat wet macular degeneration and works by inhibiting growth of abnormal blood vessels in the back of the eye. Avastin is administered by IV injection and is used by many ophthalmology practices, however; the use is considered"off label".
The objective of the Avastin is ultimately to prevent further vision loss. Some patients have reported some regained vision but the medication should not be expected to restore vision that has already been lost due to macular degeneration.
If you have a family history of macular degeneration or are a cigarette smoker you may choose to make some lifestyle changes that could help prevent macular degeneration in the future. Listed below are a few tips for macular degeneration prevention.